Fundraising FoxVensana Capital — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility.
BiotechHealthtechMedical DevicesHouston, US
Tim Keane(Founder)inAlex Smith(Founder)inJeffrey Tyber(Director)P. Alex Smith(Founder)inStephen Ramon(Executive Officer)inTimothy J. Keane, Jr.(Executive Officer, Director)
Board seatGreg Banker· per SEC Form D
Co-investorsArieal Southeast Angel PartnersAsymmetry VenturesEight CapitalVentureSouqY CombinatorMEDA Angels+1 more
Ventaris Surgical develops investigational medical devices that are currently under development and have not yet received FDA or other regulatory approval for commercial use.
BiotechHealthtechMedical DevicesSan Carlos, US
Surag Mantri(Executive Officer, Director)
BoardMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)in
Board seatJustin Klein· per SEC Form D
Co-investorsBoutique Venture PartnersLongitude CapitalNeotribe VenturesSCP Ventures, LLC
Apella provides real-time operating room monitoring and predictive analytics through computer vision and AI integration with EHR systems, helping surgical teams detect delays, optimize scheduling, and improve OR efficiency.
AI & Machine LearningDigital HealthHealthtech
Co-investorsK2 HealthVenturesLayout VenturesOPAMP CAPITALTwine VenturesCasdin CapitalHighlandX+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.